Carol Rossier Bradford MD
Dr. Bradford serves as the Charles J. Krause, M.D., Professor and Chair of the Department of Otolaryngology-Head and Neck Surgery and Co-Director of the Head and Neck Oncology Program within the University of Michigan Rogel Cancer Center. She has served as Director of the Head and Neck Surgery Division and Associate Chair of clinical programs and education in the Department previously.
She has long been a part of the U-M community. Dr. Bradford began her academic career at the University, and earned her B.S., M.S. and M.D. degrees here. She received her medical degree and completed an otolaryngology-head and neck surgery residency at the University of Michigan. Following her residency at U-M, she joined the faculty in 1992.
Dr. Bradford specializes in head and neck cancer surgery and reconstruction as well as cutaneous oncology and sentinel lymph node biopsy. Her research interests include identifying predictive biomarkers for response of head and neck tumors to chemotherapy and radiation and the development of novel therapeutics. Dr. Bradford has authored more than 200 journal articles and eight book chapters. Dr. Bradford has boosted our international efforts with her volunteer work as the lead surgeon of the Annual Medical Head and Neck Surgery Mission Trip to Honduras with the Christian Medical Association. Her many awards include a Distinguished Service Award from the American Academy of Otolaryngology-Head and Neck Surgery in 2007 and a listing in Best Doctors since 2001 and The Global Directory of Who’s Who since 2006. In 2009, Dr. Bradford was the recipient of the 2009 Clinical Excellence Award from Castle Connolly National Physician of the Year Awards. In 2010, she was the recipient of the University of Michigan Medical School’s Community Service Award
- University of Michigan Medical School, 1986
- University of Michigan Health System, Otolaryngology, MI, 1992
predictive markers for treatment response in head and neck cancer, human papillomavirus HPV in head and neck neoplasms, adoptive immunotherapy in head and neck tumors